Ortin Laboratories Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 21.12 million compared to INR 60.2 million a year ago. Revenue was INR 22.85 million compared to INR 60.62 million a year ago.

Net loss was INR 80.41 million compared to INR 0.936 million a year ago. Basic loss per share from continuing operations was INR 9.89 compared to INR 0.12 a year ago. Diluted loss per share from continuing operations was INR 9.89 compared to INR 0.12 a year ago.